Efficacy and Tolerability of Aliskiren/Amlodipine Single-Pill Combinations in Hypertensive Patients Who did not Respond Fully to Amlodipine Monotherapy: An 8-Week, Randomized, Double-Blind Study

被引：0
|
作者：
Pfeiffer, Dietrich [1 ]
Rennie, Nicola [2 ]
Papst, Cheraz Cherif [2 ]
Zhang, Jack [3 ]
机构：
[1] Univ Leipzig, Dept Cardiol & Angiol, Leipzig, Germany
[2] Novartis Pharma AG, Basel, Switzerland
[3] Novartis Pharmaceut, E Hanover, NJ USA
来源：
HYPERTENSION | 2011年 / 58卷 / 05期
关键词：
Aliskiren Amlodipine hypertension;
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：E119 / E120
页数：2
相关论文
共 50 条
  • [21] Results of a multicenter, 8-week, parallel-group, randomized, double-blind, double-dummy, phase III clinical trial to evaluate the efficacy and tolerability of amlodipine maleate versus amlodipine besylate in Korean patients with mild to moderate hypertension
    Park, S
    Chung, N
    Kwon, J
    Yoon, JH
    Kim, YJ
    Han, DS
    Kim, HS
    CLINICAL THERAPEUTICS, 2005, 27 (04) : 441 - 450
  • [22] Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension
    Philipp, Thomas
    Smith, Timothy R.
    Glazer, Robert
    Wernsing, Margaret
    Yen, Joseph
    Jin, James
    Schneider, Helmut
    Pospiech, Rainer
    CLINICAL THERAPEUTICS, 2007, 29 (04) : 563 - 580
  • [23] Efficacy and Safety of the Single-Pill Combination Amlodipine/Valsartan Compared to Valsartan Monotherapy in Asian Hypertensive Patients not Adequately Controlled by Valsartan Alone
    Huang, Jun
    Sun, Ning Ling
    Hao, Yu Ming
    Zhu, Jun Ren
    Tu, Ying Mei
    Curt, Valentin
    Zhang, Ying
    CIRCULATION, 2010, 122 (02) : E350 - E350
  • [24] Efficacy and safety of amlodipine/valsartan compared with amlodipine monotherapy in patients with stage 2 hypertension: a randomized, double-blind, multicenter study: the EX-EFFeCTS Study
    Destro, Maurizio
    Luckow, Anders
    Samson, Mercedes
    Kandra, Albert
    Brunel, Patrick
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2008, 2 (04) : 294 - 302
  • [25] EFFICACY OF THE SINGLE-PILL COMBINATION OF ALISKIREN 300/HCTZ 25 (+/- AMLODIPINE 5) IN HYPERTENSIVE PATIENTS NOT CONTROLLED BY THE COMBINATION OF CANDESARTAN 32/HCTZ 25
    Schweizer, J.
    Klebs, S.
    JOURNAL OF HYPERTENSION, 2010, 28 : E474 - E474
  • [26] A RANDOMIZED, DOUBLE-BLIND STUDY OF THE EFFICACY AND SAFETY OF NEW FIRST-LINE PERINDOPRIL/AMLODIPINE COMBINATIONS
    Poulter, N. R.
    Whitehouse, A.
    O'Brien, E.
    Sever, P. S.
    JOURNAL OF HYPERTENSION, 2015, 33 : E194 - E194
  • [27] SINGLE-PILL COMBINATION OF TELMISARTAN 80 MG/AMLODIPINE 5 MG PROVIDES SUPERIOR BLOOD PRESSURE REDUCTIONS TO AMLODIPINE 5 MG IN HYPERTENSIVE PATIENTS WHO WERE UNCONTROLLED ON AMLODIPINE 5 MG MONOTHERAPY
    Zhu, Dingliang
    Hu, Dayi
    Chen, Jiongjie
    Huang, Chenglei
    Zhu, Dingliang
    HEART, 2012, 98 : E254 - E254
  • [28] Effect of hydrochlorothiazide in addition to telmisartan/amlodipine combination for treating hypertensive patients uncontrolled with telmisartan/amlodipine: a randomized, double-blind study
    Higaki, Jitsuo
    Komuro, Issei
    Shiki, Kosuke
    Lee, Ganghyuck
    Taniguchi, Atsushi
    Ikeda, Hiroshi
    Kuroki, Daisuke
    Nishimura, Seiichiro
    Ogihara, Toshio
    HYPERTENSION RESEARCH, 2017, 40 (03) : 251 - 258
  • [29] Effect of hydrochlorothiazide in addition to telmisartan/amlodipine combination for treating hypertensive patients uncontrolled with telmisartan/amlodipine: a randomized, double-blind study
    Jitsuo Higaki
    Issei Komuro
    Kosuke Shiki
    Ganghyuck Lee
    Atsushi Taniguchi
    Hiroshi Ikeda
    Daisuke Kuroki
    Seiichiro Nishimura
    Toshio Ogihara
    Hypertension Research, 2017, 40 : 251 - 258
  • [30] Comparison of efficacy and tolerability of amlodipine orotate versus amlodipine besylate in adult patients with mild to moderate hypertension: A multicenter, randomized, double-blind, placebo-controlled, parallel-group, 8-week follow-up, noninferiority trial
    Hong, Soon Jun
    Ahn, Tae-Hoon
    Baek, Sang-Hong
    Cho, Wook-Hyun
    Jeon, Hyee-Kyoung
    Kyun, Jun
    Yoon, Myeong Ho
    Lee, Kwan Jeh
    Lim, Do-Sun
    CLINICAL THERAPEUTICS, 2006, 28 (04) : 537 - 551
12345